Yazar "Akkaya, Ismail Olgun" seçeneğine göre listele

Listeleniyor 1 - 2 / 2
  • Küçük Resim Yok
    Öğe
    Anomalous Origin of the Left Coronary Artery from the Pulmonary Artery (ALCAPA) in an Adult
    (Derman Medical Publ, 2013) Nazli, Yunus; Aksoy, Omer Nuri; Korkmaz, Kemal; Akkaya, Ismail Olgun; Colak, Necmettin
    Anomalous origin of the left main coronary artery from the pulmonary artery (ALCAPA), also known as Garland-Bland-White syndrome, is an extremely rare but potentially fatal congenital cardiovascular anomaly and it often exists as an isolated condition. We report an unusual case of a 32 years-old patient with ALCAPA presenting with chest pain and dyspnea who underwent surgical correction of this rare anomaly. This anomaly was simply repaired by the combination of LMCA ligation and coronary artery bypass grafting.
  • Küçük Resim Yok
    Öğe
    Assessment of the efficacy of Ankaferd blood stopper on the prevention of postoperative pericardial adhesions
    (Clinics Cardive Publ Pty Ltd, 2014) Nazli, Yunus; Colak, Necmettin; Alpay, Mehmet Fatih; Haltas, Hacer; Aksoy, Omer Nuri; Akkaya, Ismail Olgun; Cakir, Omer
    Objectives: Ankaferd has been used as a blood-stopping agent and it may also have an anti-inflammatory effect. We investigated the efficacy of Ankaferd in preventing postoperative pericardial adhesions in an experimental rabbit model. Methods: Sixteen New Zealand white rabbits were used and categorised into two groups: an Ankaferd and a control group. The Ankaferd group of rabbits was treated with a sponge impregnated with Ankaferd solution, which was applied over the abraded epicardium. A sponge impregnated with 0.9% isotonic NaCl solution was applied to the control group using the same protocol. Scores for adhesion and visibility of coronary vessels were graded by macroscopic examination, and pericardial tissues were analysed microscopically in terms of inflammation and fibrosis. Results: In the Ankaferd group, the adhesion scores were significantly higher than in the control group (p = 0.007). When the groups were compared according to the prevalence of fibrosis and degree of inflammation, the Ankaferd group was found to be statistically significantly different from the control group in terms of prevalence of fibrosis (p = 0.028). Conclusion: Topical application of Ankaferd to prevent postoperative pericardial adhesions increased adhesion and fibrosis scores.